ResearcherComprehensive Cancer Center ViennaNo recent work listed

Flora Zagouri

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7153-6556; OpenAlex author ID A5046758725. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2013: 1 paper · 2014: 2 papers

Papers 3

VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis. Co-author DOI 10.1016/j.ejso.2014.01.004 ↗
Cyclin D1, p16(INK) (4A) and p27(Kip1) in pancreatic adenocarcinoma: assessing prognostic implications through quantitative image analysis. Co-author DOI 10.1111/apm.12289 ↗
Molecularly targeted therapies in metastatic pancreatic cancer: a systematic review. Co-author DOI 10.1097/mpa.0b013e31827aedef ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Stratigoula Sakellariou · 2 shared papers, 2014 · strength 0.08
- Paper VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis. DOI 10.1016/j.ejso.2014.01.004 ↗
- Paper Cyclin D1, p16(INK) (4A) and p27(Kip1) in pancreatic adenocarcinoma: assessing prognostic implications through quantita… DOI 10.1111/apm.12289 ↗
George Zografos · 2 shared papers, 2014 · strength 0.08
- Paper VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis. DOI 10.1016/j.ejso.2014.01.004 ↗
- Paper Cyclin D1, p16(INK) (4A) and p27(Kip1) in pancreatic adenocarcinoma: assessing prognostic implications through quantita… DOI 10.1111/apm.12289 ↗
Despoina Georgiadou · 2 shared papers, 2014 · strength 0.08
- Paper VEGF and Id-1 in pancreatic adenocarcinoma: prognostic significance and impact on angiogenesis. DOI 10.1016/j.ejso.2014.01.004 ↗
- Paper Cyclin D1, p16(INK) (4A) and p27(Kip1) in pancreatic adenocarcinoma: assessing prognostic implications through quantita… DOI 10.1111/apm.12289 ↗
Rupert Bartsch · 1 shared paper, 2013 · strength 0.04
- Paper Molecularly targeted therapies in metastatic pancreatic cancer: a systematic review. DOI 10.1097/mpa.0b013e31827aedef ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.